Middletown, NJNCT06698003Now EnrollingIRB Ready

Adult T-cell Leukemia Clinical Trial in Middletown, NJ

Access cutting-edge adult t-cell leukemia treatment through this clinical trial at a research site in Middletown. Study-provided care at no cost to qualified participants.

Sponsored by Memorial Sloan Kettering Cancer Center

Quick Self-Assessment

See if you qualify for this Middletown location

Preparing your pre-screening questions...

Expert Care in Middletown

Access adult t-cell leukemia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related adult t-cell leukemia treatment provided free

Apply for This Middletown Location

Check if you qualify for this adult t-cell leukemia clinical trial in Middletown, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Middletown

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Middletown site if eligible
  4. 4Begin participation

About This Adult T-cell Leukemia Study in Middletown

The purpose of this study is to find out whether the study drug mogamulizumab is effective in preventing the development of adult T-cell leukemia/lymphoma (ATL) in people who are at higher risk for this type of cancer because they are infected with the HTLV-1 virus and because of changes seen in some of their immune system cells called T-cells.

Sponsor: Memorial Sloan Kettering Cancer Center

Who Can Participate

Inclusion Criteria

Screening Cohort (US patients only):
Age ≥18 years when informed consent is obtained
Has freely given written informed consent to participate in the study Treatment Cohorts (Cohorts 1 and 2):
Positive for anti-HTLV-1 antibody in the serum using an FDA approved assay for US patients (Avioq HTLV-I/II Microelisa System). UK patients should use UK Accreditation Service (UKAS) accredited tests, Abbot Architect ELISA Serology Screening assay and confirmatory serology Western Blot (performed at Public Health England, Virus Ref Dept, Colindale).
High-risk phenotype (PVL≥8% of PBMC)
Age ≥18 years when informed consent is obtained
Primary organ functions are stable
Neutrophil count: ≥ 1000/mm3, unless patient has diagnosis of ethnic neutropenia
Platelets: ≥100,000/mm3
Hemoglobin: ≥9.0 g/dL
Serum aspartate aminotransferase (AST): ≤1.5x upper limit of normal (ULN)
Alanine aminotransferase (ALT): ≤1.5x ULN
Total bilirubin: ≤1.5x ULN

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Middletown?

Yes, this clinical trial (NCT06698003) has an active research site in Middletown, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Adult T-cell Leukemia Treatment Options in Middletown, NJ

If you're searching for adult t-cell leukemia treatment options in Middletown, NJ, this clinical trial (NCT06698003) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Middletown research site is actively enrolling participants for this clinical trial. You'll receive care from experienced adult t-cell leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all adult t-cell leukemia clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in Middletown, NJ

See all leukemia clinical trials recruiting in Middletown — not just this study.

Browse Leukemia Trials in Middletown

Ready to Join in Middletown?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Middletown, NJ